COVAXIN Vaccine is approved for Emergency Use by WHO, iiQ8

Kuwait City, 3rd November 2021:
COVAXIN Vaccine is approved for Emergency Use by WHO, iiQ8, World Health Organization approved Covaxin
WHO has granted emergency use listing (EUL) to #COVAXIN® (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of #COVID19.
#Covaxin was found to have 78% efficacy against #COVID19 of any severity, 14 or more days after the second dose, and is extremely suitable for low- and middle-income countries due to easy storage requirements.
The Technical Advisory Group, convened by WHO and made up of regulatory experts from around the world, has determined that the #Covaxin vaccine meets WHO standards for protection against #COVID19, that the benefit of the vaccine far outweighs risks & the vaccine can be used Earth globe europe-africa.


#Covaxin vaccine was also reviewed by WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), and recommended use of this vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above. #COVID19
#Covaxin EUL expands the availability of 💉, the most effective medical tools we have to end #COVID19. It was assessed under the WHO EUL procedure based on the review of data on quality, safety, efficacy, a risk management plan & suitability in low- & middle-income countries.

iiQ8 News



Wish You Happy Diwali, iiQ8 Wishes, Happy Deepavali to All , 4th November 2021


Kuwait new conditions for Opening family and tourist visas for expatriates, iiQ8 News


Kuwait e-Visa Application – Rules and Regulations, iiQ8 , new Visa rules in Kuwait


2nd November 2021, Kuwait Corona Update today, iiQ8, COVID-19


Prepare for Next Pandemic WHO, iiQ8, World Must learn from COVID-19

November 3, 2021 5:00 PM

26 total views, 0 today